Insider Trading History of Hora Maninder

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Hora Maninder since 2016. The trader's CIK number is 1443159. At the time of the last reporting, Hora Maninder was the SVP Pharma Dev & Mfg Ops of Nektar Therapeutics. (stock ticker symbol NKTR). Also see all insider trading activities at Nektar Therapeutics.


Yearly summary of insider trading at Nektar Therapeutics (NKTR) by Hora Maninder

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 NKTR 0 $0 4,835 $177,967 0 $0
2018 NKTR 0 $0 41,629 $3,842,370 30,000 $216,299
2017 NKTR 0 $0 200,810 $4,367,657 227,300 $3,228,022
2016 NKTR 0 $0 6,757 $103,941 4,333 $0


Insider trading of Nektar Therapeutics (NKTR) by Hora Maninder

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-05-16 NKTR Sale 2,449 31.37 76,825
2019-02-19 NKTR Sale 2,386 42.39 101,142
2018-11-16 NKTR Sale 4,694 38.25 179,545
2018-05-16 NKTR Sale 4,060 83.39 338,563
2018-04-10 NKTR Option Ex 502 7.21 3,619
2018-04-10 NKTR Sale 502 105.67 53,046
2018-04-05 NKTR Sale 20,000 101.75 2,035,000
2018-04-05 NKTR Option Ex 20,000 7.21 144,200
2018-04-09 NKTR Sale 9,498 105.05 997,764
2018-04-09 NKTR Option Ex 9,498 7.21 68,480
2018-02-16 NKTR Sale 2,875 82.94 238,452
2017-11-06 NKTR Sale 5,117 25.07 128,283
2017-11-06 NKTR Option Ex 5,117 10.69 54,700
2017-11-07 NKTR Option Ex 34,600 18.10 626,260
2017-10-05 NKTR Option Ex 7,583 10.69 81,062
2017-10-05 NKTR Sale 7,583 25.00 189,575
2017-08-16 NKTR Sale 2,956 19.32 57,109
2017-05-16 NKTR Sale 2,959 19.55 57,848
2017-04-05 NKTR Option Ex 180,000 13.70 2,466,000
2017-04-05 NKTR Sale 180,000 21.70 3,906,000
2017-02-16 NKTR Sale 2,195 13.14 28,842
2016-11-16 NKTR Sale 1,654 13.96 23,089
2016-08-16 NKTR Sale 3,305 17.56 58,035
2016-05-16 NKTR Option Ex 2,167 .00 0
2016-05-17 NKTR Sale 835 13.58 11,339
2016-02-16 NKTR Option Ex 2,166 .00 0
2016-02-17 NKTR Sale 963 11.92 11,478

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hora Maninder (SVP Pharma Dev & Mfg Ops of Nektar Therapeutics at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.